vatalanib has been researched along with gsk 269962a in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (gsk 269962a) | Trials (gsk 269962a) | Recent Studies (post-2010) (gsk 269962a) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 17 | 0 | 14 |
| Protein | Taxonomy | vatalanib (IC50) | gsk 269962a (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 0.004 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.049 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 3.5 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.955 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 1.35 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 1.26 | |
| Rho-associated protein kinase 1 | Homo sapiens (human) | 0.0017 | |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.132 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 1.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
1 other study(ies) available for vatalanib and gsk 269962a
| Article | Year |
|---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |